Abingdon Health Plc (LON:ABDX – Get Free Report)’s stock price traded up 0.8% on Tuesday . The company traded as high as GBX 8.12 ($0.10) and last traded at GBX 8.06 ($0.10). 249,014 shares were traded during mid-day trading, an increase of 82% from the average session volume of 136,705 shares. The stock had previously closed at GBX 8 ($0.10).
Abingdon Health Stock Performance
The company has a debt-to-equity ratio of 46.64, a quick ratio of 1.96 and a current ratio of 1.95. The company has a market cap of £15.00 million, a P/E ratio of -899.00 and a beta of 0.13. The firm has a 50 day moving average price of GBX 7.62 and a 200-day moving average price of GBX 8.99.
About Abingdon Health
Abingdon Health is a world leading contract developer and manufacturer (CDMO) of high-quality rapid tests across all industry sectors, including healthcare, infectious disease, animal health, environmental and self-testing. Abingdon is the partner of choice for a growing global customer base and takes projects from initial concept through to routine and large-scale manufacturing and regulatory approval.
Read More
- Five stocks we like better than Abingdon Health
- What is the S&P/TSX Index?
- MercadoLibre: Latin America’s Digital Titan Just Got Cheaper
- Election Stocks: How Elections Affect the Stock Market
- Breaking Down Pegasystems, A Wedbush Top AI Pick for 2025
- What is the Hang Seng index?
- Shutterstock and Getty: A $3.7 Billion Visual Content Giant
Receive News & Ratings for Abingdon Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Abingdon Health and related companies with MarketBeat.com's FREE daily email newsletter.
